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5ABSTRACT
Background
After ischemic stroke, depression occurs in up to 40% of patients. Even after
two decades of intense research, the relationship between lesion characteris-
tics of brain infarcts such as lesion location and post-stroke depression (PSD)
is still controversial. Further, executive dysfunction, related to frontal-subcorti-
cal circuit dysfunction, has been suggested to be the core defect in patients
with geriatric or vascular depression. According to some authors, patients with
both depression and executive dysfunction (depression-executive dysfunction
syndrome, DES) may form a distinct patient group, with poor functional progno-
sis and specific treatment options. However, the neuroanatomical correlates of
executive dysfunction, or DES, are still not well established.
We wanted to study the magnetic resonance imaging (MRI) correlates of de-
pression and executive dysfunction in stroke patients and to distinguish pa-
tients with DES post-stroke by radiological and clinical characteristics. Finally,
we wanted to study the impact of PSD on functional outcome at 15 months after
stroke. Based on the existing literature, we hypothesized that lesions affecting
frontal-subcortical circuitry would be associated with depression and executive
dysfunction, and that depression at three months would have an impact on
long-term functional outcome after stroke.
Patients and methods
We assessed 486 consecutive patients aged 55 to 85 years three to four months
after ischemic stroke. A medical and neurological evaluation was carried out,
with several structured instruments for assessment of such factors as activities
of daily living (ADL), handicap, depressive symptoms, anxiety symptoms, psy-
chosocial functioning, and stroke severity. A comprehensive psychiatric evalua-
tion included the computer-assisted structured Diagnostic and Statistical Man-
ual of the American Psychiatric Association (the 3rd revised version, and the 4th
version, DSM III R and DSM IV, respectively) diagnostics, and several rating
scales. A standardized MRI protocol detailed the side, site, type, and extent of
brain infarcts, as well as extent of white matter lesions and brain atrophy. Differ-
ent aspects of executive functions were studied by widely used neuropsycho-
logical tests, and a sum score of eight different measures was calculated for
each patient to assess the presence of executive dysfunction.
6Neuroradiological correlates of PSD were studied in two patient populations. In
the first approach, we included all patients with any number of brain infarcts. Of
the original 486 patients, the 275 who had undergone both the psychiatric ex-
amination and the MRI participated (I). In the second study, we included only
those patients who had one and only one brain infarct clinically contributing to
the index stroke, plus stroke-related depression as judged by a psychiatrist
(total number of patients, 70, Study II).
Both MRI and extensive neuropsychological tests were carried out for 214 pa-
tients (Study III) to determine the association between lesion location and exec-
utive dysfunction. A psychiatric examination was performed for 158 of these
patients (Study IV), and DES was diagnosed in 21. We then studied the radio-
logical and clinical correlates of DES. At 15 months, we assessed functional
outcome and its correlates at three months after stroke by different ADL-, cog-
nition- and depression-related scales (Study V).
Results
Patients with depression had a higher number and larger volume of infarcts
affecting the prefrontal-subcortical circuits, especially the caudate, the pallidum,
and the genu of the internal capsule, with a left-side predominance. The extent
of white matter lesions and atrophy did not differ between patients with and
without depression (Studies I, II).
The mean frequency of brain infarcts in the left hemisphere was higher in the
patients with executive dysfunction.
Lesions affecting the frontal-subcortical circuits (e.g., pallidum, corona radiata
or centrum semiovale) were more frequent in patients with executive dysfunc-
tion than in those without. Furthermore, patients with pontine brain infarcts fre-
quently had executive dysfunction, but this may have been due to more exten-
sive ischemic changes in these patients in general. Extent of white matter chang-
es and central and medial temporal brain atrophy were also correlates of exec-
utive dysfunction (Study III).
The 21 patients with DES had significantly more brain infarcts affecting their
frontal-subcortical circuit structures than did the 137 patients without DES, or
the 41 patients with depression but without executive dysfunction.
Patients with DES also exhibited more severe depressive symptoms and worse
psychosocial functioning, and coped less well with complex activities of daily
living (Study IV).
7Major depression or depression as defined by the BDI (Beck’s Depression In-
ventory) cutpoint of ≥10 were associated with poor functional outcome at 15
months.
Likewise, major depression at three months was associated with a worse out-
come or dependence in ADL functions (Study V).
Conclusions
The location of the brain infarct was a determinant of PSD, executive dysfunc-
tion, and DES. The controversy in the literature regarding lesion location and
PSD is probably the result of methodological problems, e.g., weakness of com-
puter tomography in infarct characterization and inadequate diagnostic assess-
ment of depression. Further MRI-based studies in lesion location will be need-
ed to confirm our pioneering results. Our results also support the novel hypoth-
esis of  frontal-subcortical circuits as regulators of mood and emotion. Finally,
PSD at three months was also an important determinant of functional outcome
at 15 months after stroke.
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ACA Anterior cerebral artery
ADL Activities of daily living
APA American Psychiatric Association
BDI Beck’s Depression Inventory
BI Barthel Index
CADASIL Cerebral autosomal dominant arteriopathy with subcortical strokes
and vascular dementia
CT Computed tomography
CVD Cerebrovascular disease
DES Depression-executive dysfunction syndrome
DSM III Diagnostic and Statistical Manual of the American Psychiatric As-
Association, 3rd version
DSM III R Diagnostic and Statistical Manual of the American Psychiatric As-
sociation, 3rd revised version
DSM IV Diagnostic and Statistical Manual of the American Psychiatric As-
sociation, 4th version
ECT Electroconvulsive therapy
FAQ Functional Activities Questionnaire
GAF General Assessment of Functioning Scale
IADL Instumental activities of daily living
ICH Intracerebral hemorrhage
MADRS Montgomery-Åsberg Depression Rating Scale
MCA Middle cerebral artery
MMSE Mini-Mental State Examination
MRI Magnetic resonance imaging
NASCET North American Symptomatic Carotid Endarterectomy Trial
NINDS National Institute of Neurological Disorders and Stroke
OR Odds ratio
PCA Posterior cerebral artery
PSD Post-stroke depression
PSE Present State Examination
RS Rankin Scale
SAM Stroke Aging Memory Study
SAS Zung Anxiety Score
SAV Subarachnoid haemorrhage
SCAN Schedules for Clinical Assessment in Neuropsychiatry
SD Standard deviation
SSRI Serotonin-selective reuptake inhibitor
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SSS Scandinavian Stroke Scale
TIA Transient ischemic attack
WMC White matter change
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INTRODUCTION
This work concerns cerebrovascular disease (CVD), depression, frontal cogni-
tive functions, and the complex interactions of all three. Both depression and
CVD are, in this era of aging populations, receiving increasing attention. CVD is
the second most important cause of death world-wide (Murray and Lopez, 1997),
and incidence of stroke increases with age. Thus, overall age- and sex – stand-
ardized incidence rates of stroke in Europe are 9 per 1000 person-years for
individuals of ages 65 to 84, and 17 for those over 75 years (Di Carlo et al.,
2000). Although in Finland the mortality and age-adjusted incidence of stroke
are decreasing (Sivenius, 2004), the absolute number of patients is probably
increasing due to the elderly population’s extended life expectancy and increasing
size.
Stroke is caused by ischemic brain infarct in 80% of all cases, with transient
ischemic attacks and intracerebral and subarachnoidal hemorrhages being less
frequent (Bonita, 1992). The consequences of stroke are often catastrophic for
the patient, and a significant economic burden for society in the form of loss of
ability to work, loss of independence in ADL, and nursing home placement (Kaste
et al., 1998).
Depression and other neuropsychiatric aspects of stroke are still too often ne-
glected in clinical practice. In the scientific community, the importance of post-
stroke depression (PSD) has however been acknowledged, with new papers
appearing in 2004 in journals registered in the MEDLINE database numbering
50 to 60. Stroke survivors are at greatly elevated risk for clinically significant
depressive symptoms even years after stroke, independent of functional disa-
bility or previous depressive symptoms (Whyte et al., 2004). PSD is also an
important and independent correlate of poor functional outcome (Herrmann et
al., 1998) and mortality (Morris et al., 1993). Further, in stroke patients, quality
of life is seriously affected, and the most important factor causing this change is
PSD (Kauhanen, 1999). Both the human and economic burden associated with
stroke could thus be diminished by effective prevention or management of PSD
(Hachinski, 1999).
Theoretically, PSD provides a valuable model for understanding the neurobiol-
ogy and disturbances of mood regulation in general. Depression as a conse-
quence of localized brain damage helps identifying critical cerebral structures
and connections as well as neurochemical changes that may be involved in
functional depression.
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Because both depression and frontal cognitive symptoms like executive dys-
function are probably mediated by dysfunction in adjacent and overlapping frontal
neural systems and circuits (Cummings, 1993), patients with depression also
often show executive dysfunction (Royall, 1999). The frontal executive deficits,
rather than disturbance of mood or affect, may explain depressed
patients’disability. These possible associations are clinically important, as more
specific treatment of these cognitive aspects of depression may help to ensure
functional recovery.
In the present study we examined the pathoanatomical MRI correlates of both
PSD and executive dysfunction. Understanding the mechanisms and charac-
teristics of these disorders may help in identifying these patients more readily in
the future for either already existing or emerging novel and more specific treat-
ments.
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REVIEW OF THE LITERATURE
Concept of vascular depression
1. Depression in patients with vascular disease
The relationship between vascular disease and depression is complex and bi-
directional. Thus, a growing body of evidence suggests that vascular diseases
increase risk for subsequent depression. On the other hand, depression is a
risk factor for subsequent vascular disease and stroke.
The reported prevalence of depression in elderly people varies among studies.
In community-based studies using DSM III and IV criteria, the prevalence of
major depression is about 3 to 5% and that of minor depression usually two to
four times higher (Kivelä, 2002, Gallo and Lebowitz, 1999). In a recent US pop-
ulation-based study focusing on the general elderly population aged 65 to 100
(Steffens et al., 2000), the point prevalence of major depression among the
non-demented was estimated to be 4.4% for women and 2.7% for men. In Fin-
land, a lower prevalence of major depression has emerged from the Health
2000 Study, being 1.1% for males and 2.7% for females (Pirkola et al., 2005).
In patient populations the prevalence is higher. Elderly patients in general prac-
tice are probably more affected, and the prevalence of “clinically significant”
depression (defined by rating-scale cut-points) has been between 17 and 30%
(Callahan et al., 1994, Evans and Katona, 1993). In patients with vascular dis-
eases, however, major depression is even more prevalent. For example, of
inpatients recovering from heart infarct around 20% may suffer from major de-
pression (Hance et al., 1996, Frasure-Smith et al., 1993).
Depression is probably a more common feature of vascular dementia than of
Alzheimer’s disease (Newman, 1999). Silent (causing no neurological symp-
toms) brain infarcts are significantly more common in elderly depressed pa-
tients than in  non-depressed subjects (Fujikawa et al., 1993). This association
is even clearer in those patients with late-onset depression and without a family
history of or with fewer psychosocial risk factors for depression (Fujikawa et al.,
1997).
The relationship between cerebrovascular risk factors (hypertension, smoking,
coronary artery disease, diabetes mellitus) and depression is less clear, how-
ever, as most of the data come from cross-sectional studies from which direc-
tionality cannot be established (Lyness, 2002, Tiemeier et al., 2004). Two
recent follow-up studies have approached this subject. In the study by Lyness
14
et al. (2000), severity of a cumulative cerebrovascular risk factor index associ-
ates significantly independently with one years depressive diagnoses–but not
after controlling for overall medical burden. Mast et al. (2004), on the other
hand, found that after controlling for baseline levels of depression, general
medical burden, limitations in activities of daily living, cognitive impairment, and
demographic variables including age, education, gender, and race, baseline
vascular burden was associated with increased odds for depression at 6- and
18-month follow-up assessments (Mast et al., 2004). Thus, vascular risk fac-
tors may also prove to be risk factors for old-age depression.
The largest body of evidence for an association between cerebrovascular dis-
ease – in the absence of frank brain infarcts – and depression comes from
neuroradiological studies. White matter and deep gray matter (i.e., basal gan-
glia) hyperintensities have been repeatedly reported as more common in pa-
tients with late-life depression (O'Brien et al., 1996, Steffens et al., 1999, de
Groot et al., 2000). Such intensities may in general be caused by unspecific
demyelination or gliosis. However, neuropathological studies have shown that
in elderly depressed patients, white matter changes (WMC) detected in mag-
netic resonance imaging are of vascular origin, especially in the frontal dorsola-
teral white matter of the brain (Thomas et al.,2002 a, 2002 b). Further, left-sided
white matter lesions seem to be more common in patients with late-onset de-
pression, suggesting lateralized lesion involvement in the pathophysiology of
depression even when brain infarcts are absent (Tupler et al., 2002). In the
periventricular white matter of depressed patients, causes of hyperintensities
are more heterogenous, but larger hyperintensities are probably markers for
cerebrovascular disease (Thomas et al., 2003a).
The idea of vascular disease as causative or as a risk factor for depression has
been widely recognized. However, even stronger evidence links previous de-
pression and subsequent vascular disease. Many large prospective studies
have shown that depression is an independent risk factor for later developing
cardiovascular disease or myocardial infarct (Thomas et al., 2004). A study by
Pratt et al (1996) suggests a dose-effect: Previous major depression has a
stronger impact as a subsequent risk factor for coronary artery disease than
does dysthymia.
Similarly, patients with depression have had an increased risk for stroke in fol-
low-up studies (Larson et al., 2001, Jonas and Mussolino, 2000). Longstanding
depression in elderly people also leads to increased mortality (Pulska et al.,
1999); this may in part be explained by excess stroke mortality in depressive
patients. Previous depression increases stroke-associated mortality even more
than do classical risk factors like smoking or high cholesterol levels (Gump et
al., 2004).
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The pathophysiological mechanisms linking depression and subsequent CVD
are unknown. Depressive elderly subjects with chronic medical illnesses are
less compliant with medical treatment regimens, and their poor adherence may
explain their increased risk for vascular morbidity (Carney et al., 1995). Other
mechanisms proposed include effects of hypercortisolemia, platelet hyperag-
gregation causing thrombosis, immunoactivation, or abnormal homocysteine
metabolism (Kales et al., 2005, Tolmunen et al., 2004).
2. Vascular depression
The many lines of evidence here presented have led some authors to propose
a novel hypothesis of vascular depression, a late-onset form of depression in
patients with established cerebrovascular disease and/or risk factors (Alexopou-
los et al., 1997a, Alexopoulos et al., 1997b, Krishnan et al., 1997), (Table 1).
Table 1. Proposed criteria for vascular depression (Krishnan et al., 1997) with
Criteria A and either B1, B2, or B3 present
A. Major depression occurring in the context of clinical and/or neuroimaging evidence of
cerebrovascular disease or neuropsychological impairment
B1. Clinical manifestations of cerebrovascular disease such as history of stroke or focal
neurological findings)
B2. Neuroimaging findings such as white or gray matter hyperintensities, confluent white
matter lesions, or brain infarcts
B3. Cognitive impairment manifested by executive dysfunction
The diagnosis may be supported by
1) Depression onset after age 50
2) Marked loss of interest or pleasure
3) Psychomotor retardation
4) Lack of family history of mood disorders
5) Marked disability in activities of daily living
The characteristic features of vascular depression have been suggested to in-
clude reduced depressive ideation, psychomotor retardation, apathy, executive
dysfunction, and delusional symptoms (Baldwin and O'Brien, 2002, O'Brien et
al., 1997), but some studies have failed to find differences between the symp-
toms of depressive elderly patients with and without vascular disease (Licht-
Strunk et al., 2004). Thus far, no consensus exists as to whether major depres-
sion criteria should be required, and how the criteria for cerebrovascular dis-
ease should be described (e.g., disease severity thresholds) (Steffens, 2004).
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3. Other vascular-related behavioral syndromes
The concept of vascular depression has been largely adopted and adapted
from that of vascular dementia, and the continuing evolution of the vascular
dementia paradigm also affects the way we think about neuropsychiatric con-
sequences of cerebrovascular disease. The DSM IV criteria for vascular de-
mentia describe an Alzheimers’ -like, memory-focused cognitive disorder, judged
to be caused by cerebrovascular disease of which either clinical or neuroradio-
logical evidence is required (American Psychiatric Association, APA; 1994).
However, the term vascular dementia is currently being replaced by a broader
and a more relevant concept of vascular cognitive impairment. This term cov-
ers a range of distinct vascular disorders leading to cognitive impairment, i.e.,
multi-infarct dementia, post-stroke dementia, subcortical vascular dementia, mild
cognitive impairment, and hereditary vascular disorders leading to cognitive
decline (O'Brien et al., 2003). It also recognizes the role of vascular factors in
degenerative dementias like Alzheimer’s disease (Snowdon et al., 1997)
The association between vascular depression and vascular cognitive impair-
ment is probably strong. They share the same risk factors, and at least some of
the pathophysiological mechanisms are similar, e.g., disruption of frontal-sub-
cortical circuitry (Cummings, 1993). Patients with vascular depression often have
cognitive symptoms, most notably executive function, which is also a hallmark
of cognitive decline in vascular cognitive impairment (Erkinjuntti et al., 2000a).
It is therefore possible that vascular depression precedes vascular dementia
(Steffens et al., 2003), and that vascular depression may be a warning sign for
imminent development of dementia. However, no studies have directly addressed
this potentially clinically important relationship.
Increased white matter intensities have also been shown in patients with bipo-
lar disease, especially in the elderly patients (Aylward et al., 1994), and these
changes are associated with poor outcome (Moore et al., 2001). However, no
evidence of any vascular origin of white matter changes in bipolar patients yet
exists.
Another important syndrome in the context of cerebrovascular disease, cogni-
tive impairment, and neuropsychiatric symptoms is cerebral autosomal domi-
nant arteriopathy with subcortical strokes and vascular dementia (CADASIL).
Patients with CADASIL typically present with transient ischemic attack (TIA) or
stroke; cognitive impairment like executive dysfunction, apathy, or full-blown
vascular dementia are present in 60% of symptomatic patients. (Dichgans et
al., 1998). Neuropsychiatric symptoms like major depression, bipolar disorder,
or delusions occur in 30% of these cases (Dichgans, 2002). Subcortical periv-
entricular white matter changes and lacunar infarcts in the basal ganglia and
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thalamus are typical neuropathological findings in these patients, again sug-
gesting the disruption of frontal-subcortical circuitry as a pathophysiological
mechanism for neuropsychiatric symptoms in cerebrovascular diseases.
Vascular depression and cognition
1. Frontal-subcortical circuits
Five differing frontal-subcortical circuits have been recognized, three of which
are associated in man with emotional and cognitive processes in man (Alexan-
der and Crutcher, 1990, Cummings, 1993). These three circuits are designated
according to site of origin in the prefrontal cortex, the dorsolateral prefrontal
circuit (originating from the convexity of the frontal lobe, Broadmann’s areas 9
and 10), the lateral orbitofrontal circuit (originating from the lower lateral parts of
the prefrontal cortex, Broadmann’s area 10), and the anterior cingulate circuit
(originating from the medially located cingular cortex: Broadmann’s area 24).
From their anatomically diverse areas of origin these circuits run closely adja-
cent to each other, although segregated, within the subcortical structures of the
caudate, globus pallidus, substantia nigra, thalamic nuclei, and interconnecting
white matter structures, e.g., the capsula interna and corona radiata, before
returning to the frontal cortex; thus forming a closed circuit (Burruss et al., 2000).
These circuits also have rich connections with the structures of the limbic cir-
cuitry, e.g., amygdala and hippocampus.
Damage to distinct circuits causes specific neuropsychological and neuropsy-
chiatric symptoms (Tekin and Cummings, 2002) Thus, damage to the dorsola-
teral prefrontal circuit has been associated with cognitive changes, especially
dysexecutive function; the orbitofrontal-subcortical circuit with irritability and
agitation; and the anterior cingular circuit with apathy. The circuits run closely
adjacent to each other after leaving the prefrontal cortex, and therefore are
likely together to suffer damage caused by subcortical brain infarcts. The re-
sulting clinical picture is a variable mixture of cognitive and psychiatric symp-
toms (Table 2). Depression has mostly been connected with orbitofrontal and
anterior cingular dysfunction (Ballmaier et al., 2004, Mayberg, 2001). The asso-
ciation of PSD with other syndromes like apathy (Starkstein et al., 1993) and
dysexecutive function (Leeds et al., 2001, Kauhanen et al., 1999) is under-
standable in the context of the frontal-subcortical circuitry model.
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Table 2. Neuropsychiatric symptoms and syndromes associated with dysfunction of
frontal-subcortical circuits (McPherson, 1998)
Dorsolateral circuits Orbitofrontal circuits Anterior cingular circuits
Executive dysfunction Personality change Apathy
Working memory disturbances Poor judgement Abulia
Motor planning and sequencing
disturbances Irritability Akinetic mutism
Hypomania and mania Amotivation
Impulsivity Depression
Depression
2. Executive dysfunction in patients with cerebrovascular disease
Executive functions are high-order cognitive processes necessary for complex,
goal-oriented behavior. They include control and regulation of behavior and are
critical for novel problem-solving (Rabbitt, 1997). The APA’s Diagnostic and Sta-
tistical Manual, 4th Edition (DSM IV) (APA, 1994) defines executive functions as
the ability to think abstractly and to plan, initiate, sequence, monitor, and cease
complex behavior; to shift mental sets, generate novel verbal or non-verbal
information, and to execute serial motor activities. Thus, executive functions
are often viewed as distinct cognitive functions directly measurable by neu-
ropsychological testing.
A more cybernetic approach to executive functions is also emerging (Royall et
al., 2002). Here executive functions are seen as central controlling functions,
interacting, sequencing, and organizing non-executive processes as well (e.g.,
motor, emotional, and sensory processes). Executive dysfunction could also
express itself as disorganized operations of non-executive domains, such as
hallucinations in patients with schizophrenia (Andreasen et al., 1998).
Executive dysfunction is probably one of the central defects (Royall et al., 2002)
in a wide spectrum of neuropsychiatric disorders like schizophrenia (Pantelis et
al., 1997), traumatic brain injury (Hanks et al., 1999), late-onset depression
(Alexopoulos et al., 2002), or vascular dementia (Roman and Royall, 1999). It
compromises coping in non-routine tasks and complex ADLs (Grigsby et al.,
1993), thus endangering independent functioning and increasing institutionali-
zation of patients with chronic neuropsychiatric conditions.
Lesions affecting the dorsolateral prefrontal cortex cause executive dysfunc-
tion (Grafman and Litvan, 1999), but damage to the frontal-subcortical circuits
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and their thalamocerebellar connections may have similar effects also in sub-
cortical (Cummings, 1995, Kramer et al., 2002) and posterior (Schmahmann
and Sherman, 1998) areas. In healthy individuals, executive dysfunction has
been associated with the volume of WMCs assessed by MRI (DeCarli et al.,
1995). Clinically significant executive dysfunction is also a frequent consequence
of ischemic stroke, associating with dementia and disability (Pohjasvaara et al.,
2002a). The few existing case studies or patient series reporting anatomic
location of the brain infarcts in stroke patients (Caplan et al., 1990, Ghika-Schmid
and Bogousslavsky, 2000, Sandson et al., 1991, Van Der Werf et al., 1999,
Wolfe et al., 1990, Mangels et al., 1996) highlight the significance of dorsolater-
al frontal, thalamic, or caudate infarcts for executive dysfunction. However, in
clinical practice, dysexecutive function is often found in patients with brain
infarcts affecting other regions of the brain, such as cerebellum.
3. Depression-executive dysfunction syndrome (DES)
Late-life depression is a heterogeneous disorder that mainly occurs in relation
to poor medical health and brain lesions, often of vascular origin (Alexopoulos
et al., 1997a). It is therefore not surprising that these patients often show de-
fects in cognitive functioning. A typical feature of late-life depression is a signif-
icant impairment in executive functions (Lockwood et al., 2002). This is clinical-
ly significant, since in patients with geriatric depression executive dysfunction
is associated with compromised instrumental activities of daily living (IADL)
(Kiosses et al., 2000, Lockwood et al., 2002), leading to increased risk for re-
lapse and for recurrence of depression (Alexopoulos et al., 2000), and to poor
response to antidepressant treatment (Kalayam and Alexopoulos, 1999). Alex-
opoulos (2001) has suggested that, in a significant subgroup of patients with
late-life depression, depressive symptoms, and executive dysfunction result
from related frontostriatal dysfunction. These patients with the DES would be
characterized by psychomotor retardation and reduced interest in activities, but
with a less pronounced vegetative syndrome than that of those elderly depressed
patients without significant executive dysfunction (Alexopoulos et al., 1996).
Targeted studies of novel pharmacological agents known to modulate the fron-
tostriatal functions, e.g., opiate agonists, dopamine agonists, and cholinergic
agents, might prove useful in this specific group of depression patients (Alex-
opoulos et al., 2002)
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Post-stroke depression
1. Prevalence of post-stroke depression (PSD)
Folstein et al reported in 1977 that when they compared 20 stroke patients with
10 orthopedic patients with equally compromised activities of daily living (ADL),
depression occurred in 45% of the stroke patients, but among orthopedic pa-
tients, in only 10%. This is, thus far, the only study with such a direct compari-
son between patients with stroke and with other chronic disorders.
Numerous studies have addressed the prevalence of depression in stroke pa-
tients, with percentages varying from study to study, depending on time elapsed
between onset of stroke symptoms, study setting (acute inpatient vs. rehabilita-
tion phase, hospital vs. outpatient), and diagnostic criteria. Some of the essen-
tial studies reporting prevalence rates of post-stroke depression are presented
in Table 3. The estimated prevalence of depressive disorders has been around
20% to 40 %. In one recent study comparing one-year cumulative incidence of
minor and major depression between patients with ischemic stroke and myo-
cardial infarct, incidence of depression was higher in patients with stroke (38%
vs. 25%), but this difference was not significant after controlling for sex, age,
and handicap (Aben et al., 2003).
Depression is also common in other disorders that directly affect the brain. Major
depression was present in 27% of patients referred to general neurology outpa-
tient clinics for any reason (Carson et al., 2000b). In Parkinson’s disease (Cum-
mings, 1992), multiple sclerosis (Ron and Logsdail, 1989), and in outpatients
with traumatic brain injury (Kreutzer et al., 2001), prevalence of depression has
been around 40%.
In conclusion, although comparisons of reported prevalence from different pa-
tient populations are difficult, depression is clearly more prevalent in post-stroke
patients than in the general elderly population, and possibly also more preva-
lent than in patients with myocardial infarct. In patients with Parkinson’s dis-
ease, multiple sclerosis, or traumatic brain injury, the reported prevalence of
depression equals that of PSD. This indirect evidence suggests that brain injury
per se may elevate the risk for depression, in addition to the psychosocial stress
caused by severe disease.
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Table 3. Studies of prevalence and significance of lesion location in post-stroke
depression
Source N Setting Prevalence Association Depression Time from
of depres- between lesion criteria stroke to
sion (%) location and assessment
depression
Robinson 36 Inpatient 44 Left side more DSM III Major Acute
et al., 1984 common and minor
depression
Sinyor et al, 35 Rehab 40 Right side Major and 2 weeks
1986 more common minor
depression
Starkstein 45 Inpatient, 31 Left side more DSM III Major Mean, 20 days
et al., 1987 rehab common and minor
Dam et al., 92 Inpatient, 30 No difference Research Mean, 35 days
2001 outpatient diagnostic
criteria (RDC)
Sharpe et al., 60 Community 18 No difference Any DSM-III-R 3 to 5 years
1990 depression
House et al., 73 Community 11 (one No difference DSM III Major 1, 6, and 12
1989b month) to 5 months after
(12 months) stroke
Schwartz 91 Rehab 40 Right side Major and 3-9 months
et al., 1993 more affected minor
in depression depression
Åström M 80 Inpatients 25 (acute Left anterior DSM III major Acute phase-3
et al., 1996 stage), 31 (3 lesion more depression years
months), 16 common in
(12 months), acute stage,
29 (3 years) not later
Herrmann M 47 Inpatients 36 Left basal Any DSM-III-R <2 months
et al., 1995 ganglia lesions depression
were correlated
to depression
Andersen 285 Inpatient, 30 No difference Major 1 month
et al., 1995 outpatient depression
MacHal 145 Inpatient 20 Right DSM IV major 6 months
et al., 1998 hemisphere and minor
more common
Gainotti 153 Inpatients, 27 (<4 months) No difference DSM III R 2 weeks to
et al., 1999 rehab 40 (>4 months) Major 6 months
depression
Kim and 148 Outpatients 18 No differences DSM IV major 2-4 months
Choi-Kwon, between depression
2000 hemispheres,
anterior more
common than
posterior
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2. Relationship between lesion location and PSD
The association between location of brain damage and subsequent changes in
behavior has been demonstrated in classic neuropsychology, i.e., in aphasic or
amnestic disorders. Current knowledge in neurobiology emphasizes the model
of wide-distributed neural networks, rather than strictly localized brain areas as
the anatomical basis of distinct complex brain functions. However, there may
exist some critical “relay areas” or areas of anatomical proximity of different
neural networks that, when damaged, may give rise to disturbances in behavior
or affect.
PSD is an important subtype of vascular depression. In vascular depression,
the disruption in the mood-regulating circuits may be caused by white-matter
changes, whereas in post-stroke depression, brain infarct or hemorrhage caus-
es this disruption. The significance of frontal-subcortical structures in
depression is evident also from both structural (Soares and Mann, 1997)
and functional (Drevets, 2000) studies of endogenous, “non-organic” depres-
sion. Abnormal findings are repeatedly reported in the prefrontal cortex, stria-
tum, and thalamus; but also in the classical limbic structures, especially the
amygdala.
Robinson and colleagues from the University of Iowa, USA, were the first to
focus on laterialization of behavioral and biochemical responses after cerebral
infarction, using an experimental stroke model. They showed that spontaneous
activity increased in association with decrease in norepinephrine concentra-
tions in rats with right-sided lesions, whereas no biochemical or behavioral chang-
es were noted in rats with left-sided lesions (Robinson et al., 1975, Robinson,
1979). Their further studies concentrated on the relationship between lesion
location and depression after brain injury in humans (Robinson and Szetela,
1981). They showed that depression, as well as severity of depressive symp-
toms, was associated with the anteriority on computed tomography (CT) of the
brain lesion. Further, left-sided lesions, particularly left anterior lesions, were
associated with PSD (Robinson et al., 1983b, 1984, Starkstein et al., 1987)
After the seminal work by the Robinson group, more than fifty studies have
appeared addressing the correlation between stroke lesion location and de-
pression. The most prominent studies are presented in Table 3. Starkstein et al.
(1988) first showed that patients with left-sided basal ganglia lesions more fre-
quently had more frequent depression than did patients with right–sided or tha-
lamic lesions; depressive symptoms were also more severe in association with
left-sided basal ganglia lesions. Since then, many studies have consistently
shown that lesions affecting basal ganglia and frontal structures associate with
PSD (Morris et al. 1996, Kim and Choi-Kwon, 2000).
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Virtually all studies of lesion location and PSD have applied CT methodology in
characterizing the stroke lesion and its location, and most have recruited only
patients with a single stroke lesion. The results of the many studies in this field
are conflicting: some report no association with lesion location and depression;
some find associations with right-sided lesions and depression. Robinson
(1998a) has suggested that the relationship between PSD and lesion location
is dynamic, so that the association exists in the acute phase after stroke but not
in later stages, i.e., three months after stroke. This explanation is in accordance
with findings of some follow-up studies (Shimoda and Robinson, 1999, Åstrom
et al., 1993). However, Carson et al (2000) have argued strongly against the
“left anterior hypothesis” in their systematic review of the existing studies in this
field. Their fixed-effects and random-effects meta-analysis of the pooled data
from 48 studies found no evidence for the lesions of the left hemisphere or of
the left anterior brain being critical in PSD. This meta-analysis has in turn been
criticized for not taking into account past psychiatric history, prior brain injury, or
subcortical atrophy – all potentially important contributors to the association
between brain infarct and subsequent depression (Whyte and Mulsant, 2002).
All in all, the association between stroke lesion location and depression, and
indeed the concept of post-stroke depression as a biological vs. psychosocial
form of depression is still controversial. This field is plagued by a high number
of studies using different and in part contradicting methodologies and defini-
tions and thereby reaching confusing results. To clarify matters, many authors
have suggested standardization of the protocols in future PSD studies (Singh
et al., 1998, Bhogal et al., 2004, Turner-Stokes, 2003, Aben et al., 2003). Among
the key problems still to be resolved are
. Lack of standardized and appropriate measure for depression in stroke pa-
tients, i.e., patients with communicative problems like aphasia, neuro-
psychological problems like neglect, or neuropsychiatric symptoms like
apathy or fatigue not necessarily caused by depression
. Identification of a representative population source; i.e., hospital-based vs.
outpatient setting
. Optimal time after stroke outset to interview for PSD; a prospective follow-up
study should probably be preferred to cross-cut studies
. Ideal neuroradiological assessment; probably a blinded protocol with speci-
fied methods for brain infarct identification, assessment of brain atrophy,
and white matter changes
. Significance of various host factors, i.e., social support, disability after stroke,
pre-stroke depressive episodes, family history of depression, or medica-
tions
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3. Other possible pathophysiological mechanisms of PSD
Neurotransmitter changes contributing to development of PSD are unclear. Stud-
ies of receptor binding in animal models and human patients as well as fenflu-
ramine challenge studies (to measure the effect of fenfluramine-induced serot-
onin increase on serum prolactine levels) suggest that disturbances in the me-
tabolism of dopamine, serotonin and norepinephrine may be involved (Robin-
son, 1998a, Ramasubbu et al., 1998a).
Theoretically, stroke-associated deleterious neuroplastic changes may also af-
fect mood and increase risk for PSD. Neuronal damage may lead to impair-
ments in signaling pathways that regulate neuroplasticity and cell survival. The
resulting decreased expression of brain-derived neurotrophic factors in popula-
tions of stress-vulnerable hippocampal neurons may be involved in depression.
(Duman et al., 1997, Manji et al., 2001).
Although biological explanations for PSD are, however, intriguing, like any oth-
er psychiatric condition, it is a multidimensional disorder with biological and
psychosocial aspects. Among reported risk factors for PSD are premorbid neu-
rotic personality (Aben et al., 2002), family history of depressive disorders, and
previous depressive episodes (Morris et al., 1992). Furthermore, major life events
other than stroke (Bush, 1999), living alone before stroke, female gender, so-
cial stress before stroke (Andersen et al., 1995), and stroke severity and disa-
bility after stroke (Pohjasvaara et al., 1998b) are associated with PSD. Thus,
the psychosocial factors should not be forgotten in the clinical practice or in
research on this disorder.
4. Treatment of post-stroke depression
The biology behind endogenous and post-stroke depression probably differs,
the latter occurring as a result of acute brain damage in contrast with the less
robust brain dysfunction of endogenous depression. Therefore, the treatment
algorithms for endogenous depression may not necessarily be applicable to
PSD. At present, eight controlled studies address this question, in addition to
open-label studies. Among the compounds studied are fluoxetine (Wiart et al.,
2000, Fruehwald et al., 2003), citalopram (Andersen et al., 1994), nortriptyline
(Lipsey et al., 1984, Robinson et al., 2000), trazodone (Reding et al., 1986),
reboxetine (Rampello et al., 2004), and methylphenidate (Grade et al., 1998).
Data from these studies suggest that PSD does respond to antidepressants
with their differing modes of action at a rate comparable to that of endogenous
depression. No serious adverse effects occurred in any of these studies. Final-
ly, a recent Cochrane review found evidence of reduction in depression rating
scales but no evidence of increased total remission associated with antidepres-
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sive medication after stroke (Hackett et al., 2004). This is an understudied field,
however, and clinical experience encourages us to avoid nihilism in biological
treatment of PSD.
What is the drug of choice for PSD? A trial by Robinson et al (2000) showed that
for treatment of PSD, nortriptyline, a tricyclic compound, is superior to fluoxet-
ine and to placebo. Theirs is the only post-stroke depression study thus far with
a head-to-head comparison between two compounds. However, anticholiner-
gic (e.g., glaucoma, urine retention, and cognitive deterioration) and potential
cardiotoxic effects of nortriptylene clearly limit its usefulness in elderly patients
with cerebrovascular disease. Sertraline has been proven safe and effective for
depression after myocardial infarct (Glassman et al., 2002), suggesting a favor-
able safety profile for that drug also in other serious vascular disorders like
stroke. As a group, the selective serotonin reuptake inhibitors (the SSRIs) prob-
ably have fewer side effects and contraindications in post-stroke patients than
do tricyclic antidepressants and are more feasible to use (Cole et al., 2001).
Novel agents like mirtazapine, venlafaxine, and reboxetine seem to be safe
and effective for PSD in our clinical experience, supported by some open-label
trial data (Dahmen et al., 1999).
Electroconvulsive therapy (ECT) is probably also safe and effective for PSD
(Currier et al., 1992). Although case reports (Weintraub and Lippmann, 2000)
show ECT to be safe even in the postacute phase (7 to 14 days after stroke), it
is probably advisable to wait few weeks before ECT to avoid ischemic compli-
cations (Miller and Isenberg, 1998).
0Although no controlled trials of different psychotherapeutic approaches in pa-
tients with PSD exist, the value of supportive psychotherapy, psychoeducation,
and family support in clinical practice is hard to deny. Of the more structured
therapy modalities, cognitive psychotherapy is probably worthy of considera-
tion in patients retaining communicative and cognitive skills (Kneebone and
Dunmore, 2000, Lincoln et al., 1997).
5. Prognosis of post-stroke depression
Several studies have shown that depression has a deleterious effect on prog-
nosis after stroke. Thus, in one prospective study of 63 stroke patients, the 25
patients with PSD did not differ from those without PSD during acute hospitali-
zation in regards to impairment in ADLs, neurologic diagnoses and findings,
lesion location and volume on CT, demographic variables, cognitive impairment,
or social functioning. However, at two years after stroke those patients with
either minor or major PSD were significantly more impaired in ADLs than were
the others (Parikh et al., 1990). Numerous other studies have reported associ-
ations between functional disability and PSD, but it has been difficult to con-
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clude whether PSD has influenced disability or vice versa (Åström et al., 1993,
Ramasubbu et al., 1998b, Singh et al., 2000). The negative effect of depression
on functional outcome has also been shown in rehabilitation studies post stroke.
Patients with PSD spend a longer time in rehabilitation programs, and their use
of rehabilitation services is less efficient (Gillen et al., 2001). Thus, the effect of
rehabilitation on recovery from stroke is clearly and negatively affected by PSD
(Paolucci et al., 2001).
Cognitive decline as measured by decrease in Mini-Mental State Examination
(MMSE) score in association with PSD has often been reported in many studies
(Robinson, 1998c), but the proportion of patients with PSD developing demen-
tia within certain time periods, say within a year after stroke, is unknown.
Depression also affects stroke patients’ quality of life. In many studies, PSD has
been called one of the most important correlates of post-stroke quality of life, in
addition to functional disability, family and social support, and subcortical stroke
lesion location (Jaracz and Kozubski, 2003, Kauhanen et al., 2000, Carod-Artal
et al., 2000, Moon et al., 2004).
Mortality after stroke in patients with depression is significantly higher. Morris et
al. (1993) followed 91 stroke patients for 10 years and found that those patients
with either minor or major depression at two weeks after stroke were 3.4 times
as likely than non-depressed subjects to have died during that time. Similar
findings have recently been reported from a large, register-based study of 51,119
American veterans, each hospitalized after an ischemic stroke. The hazard ra-
tio of death within three years after stroke was 1.13 (CI=1.06-1.21) for patients
with depression, despite their being younger and having fewer chronic condi-
tions (Williams et al., 2004).
Recently, trials of antidepressive medications to prevent these adverse out-
comes in stroke patients have been carried out. Narushima and Robinson (2003)
found that a three-month course of antidepressive medication in stroke patients
with and without depression was effective in reducing functional impairment at
21 months after stroke, but there seemed to be a time-window: The medication
was significantly more effective in prevention of disability when introduced ear-
ly, during the first month post-stroke, rather than later introduction of medica-
tion. In a controlled trial of mianserin for prevention of PSD, however, antide-
pressive medical treatment failed to affect stroke outcome (Palomäki et al., 1999).
Jorge et al. (2003) randomly assigned 104 patients to receive a 12–week dou-
ble-blind course of nortriptyline, fluoxetine, or placebo during the first six months
after stroke. They found significantly more patients of the treatment group (68%
vs. 36%) to be alive at 9-year follow up. Thus, antidepressive medication may
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improve functional outcome and survival in patients with ischemic stroke, with
and without depression.
Post-stroke depression has a negative impact on many aspects life after stroke,
but what is the prognosis and natural course of the PSD itself? Robert Robin-
son et al. (1998b), in a number of papers addressing this matter, suggest that in
at least half these patients, the depression tends to last for at least eight months.
However, in most cases, the patients improve even without treatment, and re-
mission rates are similar to those in endogenous depression. Thus, at one year
after depression, 75% percent of the patients were in remission. While this mostly
favorable prognosis is reported also in other studies (Burvill et al., 1995, Morris
et al., 1990), a study by Åström et al (1993) suggests that 40% of patients with
early (onset at 0 to three months after stroke) major depression were not in
remission at one year after stroke, and had a high risk for chronic depression.
To sum up, the long-term prognosis for PSD is still an open question, with fur-
ther studies in this field needed.
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AIMS OF THE STUDY
Our basic hypotheses were that location of brain infarcts and other vascular-
related brain lesions are associated with depression and executive dysfunc-
tion, and that PSD is associated with a worse outcome at one year in stroke
patients.
. To study the neuroradiological correlates of post-stroke depression by use
of MRI. Based on the existing literature, we expected to find that lesions of
frontal-subcortical circuitry would increase risk for PSD (Studies I and II).
. To evaluate the association between lesion location and executive dysfunc-
tion in stroke patients. As frontal control of executive functions and mood
may be mediated by closely adjacent frontal-subcortical circuits, we expect-
ed to find that lesions of frontal-subcortical circuits would also be associated
with executive dysfunction (Study III).
. To discover whether lesion locations would differ between patients with and
without depression, with and without executive dysfunction. We hypothe-
sized that in patients with both depression and executive dysfunction, fron-
tal-subcortical lesions would be especially common. We also sought other
correlates for this clinically potentially important patient group of DES (Study
IV).
. Finally, we wanted to highlight the significance of PSD the outcome after
stroke by assessing the correlation between depressive symptoms at three
months after stroke and functional outcome after 15 months’ follow-up. We
hypothesized that depression would negatively affect outcome in stroke pa-
tients (Study V).
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SUBJECTS AND METHODS
Subjects
The present study is part of the Stroke Aging Memory Study (SAM), of which the
detailed procedures have been described (Pohjasvaara et al., 1997). Briefly, all
1622 patients admitted to Helsinki University Central Hospital with symptoms of
possible ischemic stroke were evaluated for inclusion by a clinical neurologist.
Stroke was diagnosed in 1447. Further inclusion criteria were:
. Age 55 to 85 years
. Fulfilling the current criteria for stroke (WHO, 1989, NINDS, 1990, NASCET,
1991).
. Symptoms not caused by subarachnoidal or intracerebral hemorrhage
. Residence in the city of Helsinki
. Mastery of the Finnish language
All 642 patients fulfilling the inclusion criteria were invited to a follow-up visit to
be held three months after stroke. Of those invited, 71 (11.1%) had died before
this visit, 82 (12.8%) refused, and 3 (0.5%) could not be reached. A total of 486
patients were thus included in the SAM cohort.
No difference existed between the ages of the 85 who refused or could not be
reached, and of those included (79.2±7.7 vs. 71.2±7.6 years, NS). However,
those patients not included were more often female (67.1% vs. 49.2%, P<0.05)
and were more often living in institutions at the time of examination (60.0% vs.
16.8%, P<0.001).
Three months after the index stroke, board-certified neurologists carried out a
detailed structured clinical and neurological examination. A senior neurologist
reviewed all the cases. According to the study protocol, a psychiatrist and a
neuropsychologist then examined the patients, followed by MRI of the head as
well as basic laboratory evaluations. The cohort of patients recruited for psychi-
atric examination was smaller (N=275) than the basic study cohort (N=486).
This resulted from a shorter recruitment period for patients for psychiatric eval-
uation: the recruitment of consecutive patients for the psychiatric study started
three months after, and ended one month before the recruitment period for
other procedures.
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Figure 1. Patient flow
Deafness 1
Aphasia 32
MRI not done 63
-severe illness ¨            12
-obesity 1
-refusal 21
-claustrophobia 2
-contraindication 27
Psychiatric examination
not possible at 3-4 mo 85
Refused psychiatric
examination 30
Evaluation at 3 months 486
Not fulfilling
inclusion criteria 507
Death 71
SAV or ICH 298
Refusal 82
Not identified 3
Clinical diagnosis of
Stroke 1447
MRI and psychiatry
(Study I)
N=275
Only one infarct visible
in MRI
(Study II) N=70 
Evaluation at 15 months
carried out (Study V)
276 patients
Neuropsychology not possible 134
Aphasia 37
Lack of co-operation 23
Refusal 15
Non-fluent Finnish 5
Deafness 4
Neglect 6
Agnosia 3
Illiteracy 2
Impaired conciousness 1
DSM III dementia 35
MRI not done 7
MRI and 
neuropsychology
(Study III) N=214
MRI, neuropsychology
and psychiatry
(Study IV) (N=158)
No psychiatry N= 56
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At 15 months after the index stroke, the patients were contacted to arrange a
follow-up visit to a neurologist or study nurse, or if not possible, a telephone
interview with the patient and a knowledgeable informant (usually a caregiver).
A different cohort of the original 486 patients took part in each of the separate
studies (I to V) of the present work because of different exclusion criteria and
reasons for dropout in individual studies. The patient flow and reasons for non-
enrollment are presented in Figure 1. The most common reason for exclusion
in Studies I, II, and IV was lack of a psychiatric examination. Enrollment of pa-
tients for this examination started somewhat later than for other assessments,
thus diminishing the cohort size. Patients excluded from psychiatric evaluation
(Studies I, II, IV, and V) were more often dependent in ADL (52% vs. 35%,
P<0.001), had more severe physical handicaps [Barthel Index (BI) score 16.5
vs. 18.4, P<0.001] , more cognitive disturbances as measured by MMSE (24.5
vs. 25.8 pts, P<0.05) and a more severe stroke as measured by the Scandina-
vian Stroke Scale (SSS) (50.2 vs. 54.0, P<0.001).
The Study I included 275 patients who had MRI and a psychiatric examination.
Patients with a history of depressive disorders (N=54, 19.6%) and previous
stroke (N=83, 30.2%) prior to the index stroke were included. Reasons for ex-
clusion are indicated in Figure 1.
For Study II, we excluded patients with no visible brain infarct (N=13) or more
than one infarct (N=192); patients with other previous psychosocial stress fac-
tors except stroke, and patients with previous depressive episodes were also
excluded. The remaining 70 patients were considered to represent purely stroke-
related depression. The excluded patients did not differ from those included
(N=70) with regard to sex, age, or functional status in ADLs as assessed by the
BI (data not shown). Neither the cognitive differences as defined by MMSE
score (excluded vs. included, 25.7±4.0 vs. 26.0±4.0, P=NS, Mann-Whitney test)
nor percentage of patients with DSM III R diagnosis of dementia (excluded vs.
included, 19.6% vs. 15.4%, P=NS, χ2 -test) reached statistical significance be-
tween the two groups.
For Study III 90 patients were excluded from the original 486. Reasons for ex-
clusion were severe aphasia (n=37), lack of cooperation (n=23), refusal (n=15),
non-fluency in Finnish (n=5), severe hearing or visual impairment (n=4), severe
neglect (n=3), illiteracy (n=2), or reduced level of consciousness (n=1). The
remaining 396 patients were eligible for neuropsychological testing and MRI.
Extensive neuropsychological testing focusing on executive functions proved
to be too demanding for 134 patients. These patients belonged to the more
elderly and the cognitively more impaired group, in whom fatigue often prevent-
ed completion of the test protocol. An additional six patients were excluded
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because of cognitive deficits (neglect, n=3; visual agnosia, n=2; and neglect
with visual agnosia, n=1), and seven patients had not undergone MRI. Patients
with dementia (N=35) according to the DSM III criteria were excluded. Thus,
the final number of patients in Study III was 214. We compared the excluded
(N=272) and included (N=214) patients and found the excluded patients to be
older (72.8±7.7 vs. 69.1±7.1 years, P<0.001), more often dependent (62.5%
vs. 16.4%, P<0.001), had had a more severe stroke as measured by SSS
(4.9±6.4 vs. 1.4±2.6 points, P<0.001), were more impaired in activities of daily
living as measured by the BI (16.1±5.3 vs. 19.5±1.7 points, P<0.001) and had
more cognitive deterioration as measured by the MMSE (22.9±5.4 vs. 27.6±2.0
points, P<0.001).
Study IV included all patients from the Study III cohort who had also undergone
psychiatric evaluation.
For Study V, we enrolled those 276 patients whom we were able to evaluate at
15 months after stroke. Of the original 486, 25 had died, 5 could not be reached,
and 66 could not be assessed in detail. In the remaining 390 patients, BDI could
be completed in 276 patients 15 months after stroke. When we compared the
210 excluded patients with the 276 included, no difference existed in sex, stroke
lesion localization, or history of previous stroke. The patients not included were,
however, significantly older (73.1±7.4 vs. 69.8±7.5; P<0.001), more depressed
as measured by the BDI at three months (10.9±8.1 vs. 8.9±6.7; P<0.01), more
dependent in ADL functions as measured by the Barthel Index (BI, 19.0±2.5 vs.
15.7±5.7, P<0.001), more handicapped as measured by the Rankin Scale
(2.8±1.3 vs. 1.9±1.0; P<0.001), and had a lower grade of education than those
included (38.7% vs. 26.6%; P<0.01).
For neuropsychological definition of executive dysfunction, the control group
was 28 healthy elderly subjects (mean age 67 years, range, 61 to 76) recruited
from a community-based larger sample.
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Methods
1. Clinical neurological examination
Neurological examinations were performed by two board-certified neurologists.
The Mini-Mental State Examination (MMSE, maximum, 30; Folstein, 1975) was
used to assess global cognitive functioning.
The ability to carry out basic and instrumental activities of daily living and stroke-
related impairment and handicap, as well as stroke severity, were assessed by
structured interview of both the patient and a knowledgeable informant, and by
a neurologist’s evaluation. The following scales  assessed the basic and instru-
mental activity of daily living, stroke-related impairment and handicap, and stroke
severity:
. Instrumental Activities of Daily Living (IADL; maximum, 8, for instrumental
activities of daily living) (Lawton and Brody, 1969)
. Functional Activities Questionnaire (FAQ, for activities of daily living, maxi-
mum, 30) (Pfeffer et al., 1982)
. Barthel Index (BI, maximum 100, for handicap) (Mahoney F.I., 1965)
. Rankin Scale (RS; maximum 5, for impairment) (Rankin, 1957)
. The 21 /item Beck Depression scale (BDI; Beck and Beck, 1972)
. Scandinavian Stroke Scale (SSS; maximum 58, for stroke severity) (Scandi-
navian Stroke Study Group, 1985)
Dependency was defined as described by Tatemichi et al. (1994). The patient
was classified as being dependent if he required daily assistance or home at-
tendant help or was living in a nursing home or other institution.
2. Psychiatric examination
The majority of patients (n=220) were examined by a senior psychiatrist, who
also supervised the data entry of patients (n=55) examined by a resident psy-
chiatrist. Both were blinded to the radiological data. The clinical psychiatric ex-
amination was carried out after the MRI examination at 12 to 20 weeks (mean ±
SD; 15.5±1.7) after the index stroke. The examination included a computer-
assisted structured interview, Schedules for Clinical Assessment in Neuropsy-
chiatry (SCAN) (Wing et al., 1990). The main content of the SCAN is the 10th
version of the Present State Examination (PSE-10 Wing, 1974). The earlier
version (PSE 9) has been widely used in research concerning the elderly and
the physically ill patients. The Gatego-5 program computed a measure of the
severity of any psychopathology present, and the program suggested a profile
for the DSM-III-R (APA, 1987) categories. The severity and quality of depres-
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sive symptoms were assessed by the Montgomery and Åsberg depression rat-
ing scale (MADRS) (Montgomery and Åsberg, 1979), and those of anxiety by
Zung Anxiety Score (SAS) (Zung, 1971). The Global Assessment of Function-
ing Scale (GAF) was used to rate overall psychological, social, and occupation-
al functioning. The information concerning possible previous depressive epi-
sodes was obtained by interviews with the patients, relatives and caregivers.
For the final diagnoses of depressive disorders, data from the clinical psychiat-
ric examination, interviews, psychiatric rating scales, and the SCAN protocol
were combined.
Patients with depression post-stroke included those subjects with DSM-III-R
major depressive disorder (single or recurrent episode), bipolar disorders (de-
pressed episode), organic mood disorder (organic depressive disorder), ad-
justment disorder (depressed or mixed anxiety and depressed mood), dysthymic
disorder, dementia with depressed mood (as defined in the DSM-IV), and major
depressive disorder in partial remission.
3. Neuropsychological examination
The neuropsychological examination included a set of tests covering different
aspects of executive function. The number of perseverative errors and number
of categories on Nelson’s version of the Wisconsin Card Sorting Test (Nelson,
1976) was used to assess perseveration, flexibility, and ability to shift set (Ar-
nett et al., 1994, Glosser and Goodglass, 1990, Perrine, 1993). A shorter ver-
sion of the Stroop test (Perret, 1974) measured susceptibility to interference,
flexibility, and capacity to inhibit over-learned responses (MacLeod, 1991, Lowe
and Rabbitt, 1997, West and Bell, 1997). In a similar manner, two variables
from the Trail-Making A- and B- tests were used to assess maintaining and
shifting sets (Burgess et al., 1998, Arbuthnott and Frank, 2000, Wecker et al.,
2000, Reitan, 1958). Verbal fluency evaluated by semantic category (animal
naming in one minute) and letter generation (words beginning with the letter “k”
in one minute) (Lezak, 1995) served as a measure of effective memory search
strategy (Crowe, 1992).
Executive dysfunction has no generally accepted and uniform definition. We
used the performance of the control group to calculate standardized score for
eight variables: Wisconsin number of categories, number of perseverative er-
rors, Stroop division score of set B and interference score, Trail Making score of
set B and ratio between sets A and B, and the two verbal fluency scores. The
sum score from the eight variables was compared with that of the control sub-
jects. Those patients whose performance fell below 1.5 SD of the control group’s
mean score were defined as having executive dysfunction.
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4. Follow-up visit at 15 months
The assessment included the MMSE, the BI, and the BDI. Information for the
scales came from the patient, or in some cases from the relatives or caregivers,
if the patient was unable to comply. The information was gathered by a neurol-
ogist or by a trained study nurse.
Those patients with a RS scale grade of I or II, and BI points ≥17 were defined
as having a good functional outcome, and those patients who scored worse
were defined as having a poor outcome (Kotila et al., 1999). A BDI cutpoint of
≥10 points was used for depression (Pohjasvaara et al., 1998b). The sensitivi-
ties and specifities of this cutpoint when compared to the PSE/based diagnosis
at three months were 0.73 and 0.67 for major depression, and 0.73 and 0.62 for
minor depression.
5. MRI methods
MRI was performed with a 1.0 T system three to four months after the stroke.
The images were reviewed by a neuroradiologist blinded to the clinical data. To
test the reliability of the visual rating, the same rater reviewed 60 MRI scans
independently, and the results were compared to those of another neuroradiol-
ogist and a general radiologist. For the reliability of rating WMCs, the weighted
kappa values for intraobserver agreement were 0.72 to 0.95 and for interob-
server reliability 0.72 to 0.93. For the reliability of rating brain atrophy, the in-
traobserver reliability was 0.75 to 0.82, and the interobserver reliability was
0.61 to 0.74.
The number, type, side, site, and size of lesions were recorded. Lesions equiv-
alent to the signal characteristics of cerebrospinal fluid on T1-weighted images
and measuring over 3 mm in diameter, as well as wedge-shaped cortico-sub-
cortical lesions, were regarded as brain infarcts. The volume of the lesion was
estimated by the formula for calculating the volume of the ball.  We grouped the
infarcts into 4 categories based on their largest diameter (3 to 9 mm, 10 to 29
mm, 30 to 59 mm, and over 60 mm), and the radii used for calculations were 3,
10, 20, and 30 mm, respectively.
The number and volumes of infarcts affecting different anatomical sites were
evaluated a) on both sides, b) on the right side, and c) on the left side separate-
ly. The sites included: a) brain lobes (cortical-subcortical lesions in frontal, tem-
poral, parietal, and occipital lobes; b) vascular territories (deep and superficial
anterior cerebral artery (ACA), middle cerebral artery (MCA), posterior cerebral
artery (PCA), internal cerebral artery and border-zone areas) and c) specific
locations: medulla, pons, cerebellum, optic radiation, thalamus, caudate, puta-
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men, pallidum, genu of internal capsule, anterior and posterior capsule, anteri-
or and posterior corona radiata, anterior and posterior centrum semiovale, genu,
body and splenium of corpus callosum, angular gyrus, hypothalamus, hippoc-
ampus, and amygdala. Prefrontal-subcortical circuits (Cummings, 1993) include
afferent basal ganglia connections from the frontal cortex to the caudate, palli-
dum, and thalamus; and efferent thalamocortical connections via genu of the
internal capsule, anterior capsule, anterior corona radiata, and anterior cen-
trum semiovale back to frontal cortex.
WMCs were rated on proton density-weighted images in six areas: around the
frontal and posterior horns and along the bodies of the lateral ventricles, in
subcortical, deep, and watershed areas (Mäntyla et al., 1997,1999). Periven-
tricular WMCs around the frontal and posterior horns were classified based on
size and shape into small cap (≤5 mm), large cap (6–10 mm) or extending cap
(>10 mm); and WMCs along the bodies of lateral ventricles into thin lining (≤5
mm), smooth halo (6–10 mm), or irregular halo (>10 mm). WMCs in the subcor-
tical, deep, and watershed areas were classified based on size (greatest diam-
eter) and shape into small focal (≤5 mm), large focal (6–10 mm), focal confluent
(11–25 mm), diffusely confluent (>25 mm), and extensive WMC (diffuse hyper-
intensity without distinct focal lesions affecting the majority of the white matter
area). The number for each type of hyperintensity was counted, and extensive
WMCs were rated as absent or present.  Moderate and severe degree of WMCs
included large and extending caps in the periventricular area; smooth halo and
irregular halo along the bodies of lateral ventricles; and focal confluent, diffuse-
ly confluent, and extensive WMCs in the subcortical, deep and watershed are-
as. The extent of WMCs was also graded on the four-point scale of Fazekas et
al (1987).
Brain atrophy was rated as none, mild, moderate, or severe, by comparison
with standard images according to the methods of Scheltens et al (1992) and
Erkinjuntti et al (1993). Cortical atrophy was rated in frontal, parietal, and occip-
ital lobes, central atrophy in temporal, frontal, and occipital horns and bodies of
the lateral ventricles, and medial temporal lobe atrophy in the entorhinal cortex
and hippocampus. Cortical and central atrophy was expressed as the mean of
the rating in all the bilateral areas rated and divided into two groups: none to
mild vs. moderate to severe atrophy.
Data analysis and statistics
The Fisher exact test (2-tailed) was applied for categorical data and the Mann-
Whitney non-parametric test for continuous data in Studies I to IV. In Study V,
the χ2 -test was applied for categorical data, and the pooled t-test for continu-
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ous data. No adjustments were made for multiple comparisons in statistical
approaches. The α-level of significance was P <0.05 throughout. Logistic re-
gression models were used for the analyses of significant contributors of PSD,
executive dysfunction, and DES. The statistics were analyzed with the BMDP
(1994) and SAS (1990) programs.
Ethical approval and informed consent
The study was approved by the Ethics Committee of the Department of Neurol-
ogy, Helsinki University Central Hospital, Helsinki, Finland. The study design
was first fully explained, and written information was provided to the patients;
and if they agreed to participate, they signed an informed consent.
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RESULTS
Prevalence of post-stroke depression and executive
dysfunction
Of the 275 patients for whom both the psychiatric and MRI examination were
carried out in Study I, some depressive disorder was diagnosed in 109 (39.6%).
For clinical diagnoses see Table 4. Of the 109, the post-stroke depressive epi-
sode was the first ever for 77 (71%), with one or more depressive episodes
before the index stroke for the 32 (29%) others.Of the 275 patients, antidepres-
sive medication was used by 63 (22.9%) at three months’ follow-up. For 57 of
these 63 patients, the antidepressant was prescribed first after the index stroke,
and 42 of those 63 patients belonged to the depressed group of 109 patients.
Table 4. Depressive disorders by DSM–IV categories in the
Helsinki Stroke Aging Memory Study cohort. N total = 109
Major depression Number (%)
Depressive disorder due to stroke 5 (1.8 )
Vascular dementia with depressed mood 13 (4.7)
Major depressive disorder, single episode 42 (38.5)
Major depressive disorder, recurrent 11 (4.0)
All major depression 71 (25.8)
Minor depression
Dysthymic disorder 1 (0.4)
Adjustment disorder with depressed mood 22 (8.0)
Adjustment disorder with anxiety and depression 9 (3.3)
Major depressive disorder, in partial remission 4 (1.4)
Depressive disorder not otherwise specified 2 (0.7)
All minor depression 38 (13.8)
Depression was not associated with age, sex, education, handedness, or cog-
nitive function as measured by the MMSE, but the depressed patients were
more impaired in activities of daily living, as indicated by the difference in the BI
score; they had more severe stroke, as indicated by the SSS score; and more
often they took antidepressive medications.
Executive dysfunction was found in 73 (34.1%) of the 214 patients (Study III).
Patients with executive dysfunction were older, had a lower level of education,
were more often dependent, and had lower MMSE scores than did those pa-
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tients without executive dysfunction. There were no significant differences in
male/female ratio, in ADL functions as measured by the BI, or in presence of
depression (39% vs 39.6%, χ2 test, P=NS).
Lesion location in a naturalistic patient sample (Study I)
Most patients had more than one brain infarct on MRI. Twelve patients with no
lesion fulfilling the radiological criteria (lesion diameter larger than 3 mm) were,
however, included in the study because they fulfilled the clinical criteria for
ischemic stroke.
The total number of brain infarcts was 3.2±2.5 (mean ± SD): right hemisphere
1.7±1.6, and left hemisphere 1.6±1.4. There were no differences in overall
number of brain infarcts or in those affecting either the left or right hemisphere
between patients with and without PSD. The patients with PSD, however, more
frequently had lesions affecting the prefrontal-subcortical circuits. Within these
circuits, especially the caudate, the pallidum, the genu of the internal capsule,
and the anterior capsule were more often affected (Table 5), also with a left-
sided predominance for brain infarct location in these structures in the depressed
patients. Occipital brain infarcts in the right hemisphere were less common in
patients with PSD (Table 5).
Table 5. Mean number (SD) of brain infarcts in patients with and without depression
post-stroke in Study I.
Site Depression present Depression absent P
N=109 N=166
Occipital lobe (right side) 0.09 (0.32) 0.18 (0.41) <0.05
Caudate (either side) 0.48 (0.69) 0.31 (0.60) <0.05
Caudate (left side) 0.27 (0.49) 0.15 (0.41) <0.05
Pallidum (any side) 0.54 (0.73) 0.32 (0.61) <0.01
Pallidum (right side) 0.27 (0.45) 0.17 (0.39) <0.05
Pallidum (left side) 0.27 (0.44) 0.15 (0.36) <0.05
Genu of internal capsule (left side) 0.11 (0.31) 0.03 (0.17) <0.01
Anterior capsule (left side) 0.16 (0.36) 0.06 (0.24) <0.01
Posterior corona radiata (either side) 0.49 (0.63) 0.32 (0.50) <0.05
Posterior corona radiata (left side) 0.26 (0.46) 0.15 (0.35) <0.05
Amygdala (either side) 0.05 (0.21) 0.006 (0.08) <0.05
Frontal-subcortical circuit (either side) 1.56 (1.61) 1.16 (1.39) <0.05
Frontal-subcortical circuit (left side) 0.86 (1.0) 0.57 (0.85) <0.05
Mann-Whitney non-parametric test. Only those areas differing between depressed and not
depressed patient groups shown.
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No differences occurred in total volume of the brain infarcts as a whole or in
either left or right hemispheres between the PSD and non-PSD patients (See
Study I, Table 4., page 929). However, the depressed patients had significantly
larger lesions affecting the deep MCA territory, caudate, pallidum, genu and
anterior part of the internal capsule, posterior corona radiate, and the amygda-
la, with a left-side predominance. In contrast, patients without PSD had larger
brain infarcts affecting the right occipital lobe.
Patients with major depression (N=71) had significantly more infarcts affecting
the frontal-subcortical circuit structures than did patients with minor depression
(1.8±1.7 vs. 1.2±1.4; df=197, P<0.05, Mann-Whitney test). No difference ap-
peared in frequency of brain infarcts affecting any of the substructures (e.g.,
pallidum, caudate) of frontal-subcortical circuitry between these two groups.
No differences between the depressed and not depressed patient groups oc-
curred in the percentage of moderate to severe degree of WMCs, in the mean
Fazekas White Matter Lesion score or in the extent of central, cortical, or medi-
al temporal atrophy.
There were no differences in the volumes of infarcts, severity of WMCs, or
extent of atrophy between patients with first-ever (n=77) or recurrent depres-
sive episode (n=32). Patients with a first-ever depression episode after the in-
dex stroke had a lower frequency of brain infarcts than did the patients with
previous episodes of depression (2.8±2.4 vs. 4.1±2.6; P<0.05, df = 107; Mann-
Whitney test). This effect was even clearer in the number of right-side brain
infarcts (1.3±1.5 vs. 2.3±1.8, P<0.01). Patients with their first-ever depression
also had significantly fewer infarcts in the superficial medial cerebral artery area
(0.88±1.1 vs. 1.2±1.1, P<0.05).
Antidepressive medication was used by 63 (22.9%) of the 275 patients at 3
months’ follow-up. For 57 of these patients, the antidepressant was prescribed
first after the index stroke, and 42 of these patients belonged to the depressed
group of 109 patients.
Logistic regression analysis showed that the significant contributors for PSD
were mean frequency of infarcts in the left genu of the internal capsule (N=275;
OR 3.2; 95% CI 1.0–10.1), mean frequency of infarcts in the pallidum of either
side (OR 1.6; 95% CI 1.1–2.3), and mean volume of infarcts in the right occipital
lobe (OR 0.98; 95% CI 0.96–0.99).
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Lesion location in patients with only one infarct (Study II)
Stroke-related depression was present in 26 (37.1%) of the 70 patients with
one single brain infarct. Table 6 shows the distribution of patients according to
location of infarct. In this subanalysis we counted the number of patients with
brain infarcts affecting specific brain areas. Patients with depression more of-
ten had a brain infarct affecting the basal ganglia, mainly caudate, the putamen,
and pallidum, as well as the posterior corona radiata.
Table 6. Number (%) of patients with brain infarcts at various anatomical sites with
and without depression post-stroke in Study II.
Site Number of affected Number of affected P
patients with patients without
depression (n=26) depression (n=44)
Occipital lobe (either side) 4 (15.4) 0 (0) <0.05
Caudate (either side) 7 (27.0) 3 (6.7) <0.05
Caudate (left side) 5 (19.2) 1 (2.3) <0.05
Putamen (either side) 9 (34.6) 5 (11.4) <0.05
Pallidum (either side) 9 (34.6) 3 (6.8) <0.01
Pallidum (left side) 6 (23.1) 2 (4.5) <0.05
Posterior corona radiata
(either side) 14 (53.8) 11 (25.0) <0.05
Fisher exact test, two-tailed. Only areas differing between depressed and not depressed
patient groups shown.
The volumes of the brain infarcts that affected specific sites were larger in the
patients with PSD at the following sites (cm3, ± SD): frontal lobes (either side,
30.4±51.1 versus 7.4±2.5, P<0.05 Mann-Whitney non-parametric test), anteri-
or corona radiata (either side, 33.0±50.3 versus  7.5±24.8, P<0.05), posterior
corona radiata (either side, 34.8±49.5 versus 8.7±25.0, P<0.01; left side
17.0±36.9 versus 3.5±17.6, P<0.05), posterior centrum semiovale (either side,
30.1±47.5 versus 10.9±29.5, P<0.05), amygdala (either side 13.0±36.8 versus
0.0±0.0, P<0.05), putamen (left side, 15.8±36.9 versus 2.6±17.0, P<0.05), pal-
lidum (left side, 15.8±36.9 versus 2.6±17.0, P<0.05), frontal-subcortical circuit
(either side, 133.9±22.8 versus 33.1±13.1, P<0.05).
The extent of WMCs in the periventricular areas, centrum semiovale, subcorti-
cal areas, watershed areas, or in the mean Fazekas WMC score did not differ
between the depressed and non-depressed patient groups. Further, no differ-
ence appeared between the two groups in the grade of cortical, central, or me-
dial temporal brain atrophy (data not shown).
In the logistic regression model, the infarct localization in the pallidum of either
side was the only correlate with PSD (OR 7.2; 95% CI 1.9-35.7).
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MRI correlates of executive dysfunction (Study III)
The locations that were significantly more often affected by brain infarcts in
patients with executive dysfunction are shown in Table 7. The more brain inf-
arcts, the more likely the patient  was to have executive dysfunction, especially
when the brain infarcts were located in the left hemisphere. Lesions affecting
the frontal-subcortical circuits also were associated with executive dysfunction,
and even more clearly so in the left hemisphere. Of the 73 patients with execu-
tive dysfunction, 21 (28.8%) had a brain infarct affecting the pons, compared
with 19 (13.5%, χ2 test, P<0.01) of the 141 patients without executive dysfunc-
tion. Patients with pontine infarcts had a higher total number of brain infarcts
than did other patients (4.1±2.7 vs. 2.8±2.3, Mann-Whitney test, P<0.01). They
also had a more severe degree of white matter changes as measured by Faze-
kas white matter scoring (mean, 1.75±0.85 vs. 1.40±0.72, Mann-Whitney test,
P<0.05).
Table  7. Mean (SD) number of brain infarcts in patients with (N=73) and without
(N= 141) executive dysfunction after stroke.
Site Executive Executive P value
dysfunction dysfunction
present absent
All sites 3.66 (2.64) 2.76 (2.30) <0.05
Left side 1.93 (1.61) 1.26 (1.34) <0.01
Anterior cerebral artery
superficial (either side) 0.33 (0.65) 0.12 (0.47) <0.01
Anterior cerebral artery
superficial (left side) 0.20 (0.50) 0.06 (0.26) <0.01
Middle cerebral artery
superficial (either side) 1.11 (1.16) 0.79 (1.01) <0.05
Middle cerebral artery
superficial (left side) 0.61 (0.74) 0.33 (0.54) <0.01
Pons 0.33 (0.55) 0.15 (0.40) <0.01
Pons (left side) 0.15 (0.36) 0.04 (0.20) <0.01
Putamen (left side) 0.33 (0.50) 0.19 (0.41) <0.05
Pallidum 0.50 (0.67) 0.29 (0.60) <0.05
Anterior corona radiata (left side) 0.19 (0.40) 0.08 (0.30) <0.05
Anterior centrum semiovale (left side) 0.16 (0.37) 0.07 (0.28) <0.05
Posterior centrum semiovale (left side) 0.30 (0.49) 0.11 (0.31) <0.001
Frontal-subcortical circuit (either side) 2.59 (2.18) 1.74 (2.18) <0.001
Frontal-subcortical circuit (left side) 1.37 (1.42) 0.77 (1.32) <0.001
Mann-Whitney non-parametric test. Only areas differing between the two groups shown.
Moderate to severe white matter changes were more frequent in patients with
executive dysfunction (See Study III, Table 3., page 629). Further, moderate to
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severe central and medial temporal atrophy was more frequent in patients with
executive dysfunction.
In the logistic model, independent correlates of executive dysfunction were
MMSE score (OR 1.6, SD 1.3–1.9), low education (OR 2.5, SD 1.1–5.6), fre-
quency of left-sided pontine infarcts (OR 3.9, SD 1.1–14.2), frequency of inf-
arcts in the posterior centrum semiovale (OR 4.1, SD 1.8–9.8), moderate to
severe medial temporal atrophy (OR 2.3, SD 1.0–5.2), and Fazekas white mat-
ter score (OR 1.6, SD 1.0–2.6).
Depression-executive dysfunction syndrome (Study IV)
Depression was present in 62 (39.2%), executive dysfunction in 53 (33.5%),
and DES in 21 (13.3%) of the 157 patients (see Fig. 2). Patients with DES had
more severe cognitive dysfunction (lower score in the MMSE), more severe
depression (higher score in the MADRS), lower level of psychosocial function-
ing (lower scores in the GAF), and their complex ADL scores were lower (Table
8) than were those of the patients without DES.
Figure 2. In statistical analysis of Study IV, patients in group A compared with all
other patients, then with patients in groups B and C.
All patients N=158
No depression
or executive 
dysfunction N=64
Group B:
Depression without 
executive dysfunction
N=41
Group C:
Executive dysfunction
without depression
N=32
Group A:
Depression-executive
dysfunction syndrome
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Depressive patients with executive dysfunction had a lower MMSE score than
did those depressive patients without, and they were more often prescribed
antidepressive medication. Within the depressive patient group there was no
difference between those with, and those without executive dysfunction in sex
distribution, education level, dependence, presence of previous depressive
episodes, age, SSS score, Rankin score, the BI or GAF score (Table 8).
Table 8. Characteristics of patients with DES, with depression without executive
dysfunction, and without DES, after stroke.
Patients with  P Patients with  P Patients
DES* depression without
(N=21) and without DES
executive (N=137)
dysfunction
** (N=41)
Female sex (%) 8 (38.1) n.s. 23 (66.1) n.s. 68 (49.6)
Age (SD) 68 (8.2) n.s. 68.9 (7.6) n.s. 69 (6.6)
Low educational level (%) 6 (28.7) n.s. 7 (17.1) n.s. 27 (20.0)
Functional independence at
3 months (%) 16 (76.2) n.s. 34 (82.9) n.s. 120 (87.6)
Use of antidepressive
medication (%) 15 (71.4) <0.001 17 (41.5) <0.05 17 (12.5)
Previous depressive episode 29 (21.2) n.s. 14 (34.1) n.s. 6 (28.6)
SSS (SD) 56.4 (4.4) n.s. 55.6 (4.8) n.s. 56.7 (3.8)
Rankin (SD) 1.8 (0.8) n.s. 1.8 (0.9) n.s. 1.59 (0.9)
bADL (SD) 5.6 (6.4) n.s. 3.5 (4.1) n.s. 2.8 (4.9)
cADL (SD) 5.9 (2.1) <0.05 6.7 (1.5) n.s. 7.0 (1.5)
MMSE (SD) 25.8 (2.2) <0.001 27.8 (2.2) <0.001 27.8 (1.8)
GAF (SD) 70.6 (7.0) <0.01 71.3 (6.0) n.s. 74.9 (5.8)
SAS yht (SD) 29.0 (5.4) n.s. 32.9 (9.0) n.s. 28.1 (7.3)
MADRS (SD) 22.0 (11.8) <0.01 18.6 (9.7) n.s. 8.1 (9.1)
Fisher’s exact test (2-tailed) was used for categorical data and the Mann-Whitney non-para-
metric test for continuous data. * = compared between patients with and without DES, **  =
compared between patients with depression, with and without executive dysfunction. SSS =
Scandinavian Stroke Scale; bADL = basic activities of daily living; cADL=complex activities
of daily living; MMSE = Mini Mental State Examination; GAF = Global assessment of psycho-
logical, social and occupational functioning; SAS = Self-report anxiety inventory; MADRS =
Montgomery-Åsberg depression rating scale.
Scores of scales measuring severity of anxiety (SAS) or depression (MADRS)
did not differ between patients with DES and those with depression without
executive dysfunction, although both scores tended to be higher in patients
with DES.
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The anatomical sites significantly more often affected in patients with DES are
presented in Table 9. In patients with DES, the mean number of brain infarcts
was higher in many structures contributing to the frontal-subcortical circuit, when
compared to patients without DES. Further, when depressive patients with ex-
ecutive dysfunction were compared with depressive patients without executive
symptoms, the patients with DES had more lesions in a similar fashion affecting
these frontal-subcortical structures (Table 9).
Table 9. Frequency (SD) of brain infarcts affecting different brain locations in patients
with DES, depression without executive dysfunction, and without DES after stroke.
Patients with  P Patients with  P Patients
DES* depression without
(N=21) and without DES
executive (N=137)
dysfunction**
(N=41)
Left side (all) 2.4 (1.7) <0.01 1.2 (1.3) <0.01 1.5 (1.7)
Left superior medial
cerebral artery 0.76 (0.83) <0.05 0.2 (0.5) <0.01 0.39 (0.61)
Caudate 0.57 (0.75) <0.05 0.5 (0.8) n.s. 0.33 (0.64)
Left anterior capsule 0.24 (0.44) <0.01 0.05 (0.2) <0.05 0.05 (0.22)
Pallidum 0.71 (0.71) <0.01 0.4 (0.7) <0.05 0.30 (0.62)
Left pallidum 0.33 (0.48) <0.05 0.1 (0.3) <0.05 0.12 (0.33)
Left posterior corona radiata 0.33 (0.56) <0.05 0.1 (0.3) n.s. 0.12 (0.32)
Left posterior centrum semiovale 0.43 (0.51) <0.001 0.07 (0.3) <0.001 0.12 (0.33)
Frontal-subcortical circuits all 3.1 (2.8) <0.05 2.0 (2.6) <0.05 1.9 (2.2)
Frontal-subcortical circuits left 1.9 (1.5) <0.001 0.9 (1.5) <0.01 0.84 (1.4)
Mann-Whitney non-parametric test. * = compared between patients with and without DES.
** = compared between patients with depression with, and without executive dysfunction
(groups A and B, Fig.2.) Only those areas differing between patients with and without DES
shown.
Patients with and without DES did not differ in extent of or in white matter changes,
or in the severity of central, cortical, or medial temporal lobe atrophy.
In the logistic models, the only correlate with DES was number of brain infarcts
affecting frontal-subcortical circuits on the left side (OR 1.6; 95% CI 1.1–2.5).
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Depression as a predictor of poor long-term functional
outcome (Study V)
Depression as defined by the BDI cutpoint of ≥10 points was present in 43.9%
of the patients at three months, and in 44.6% of the patients at 15 months post-
stroke. Only 31.9% of the depressed patients took antidepressive medication at
three months after stroke, but this medication did not affect the functional out-
come at 15 months (RS I–II, 33.9% vs. 31.8%).
Major depression or depression as defined by a BDI cutpoint of ≥10 were asso-
ciated with a poor functional outcome at 15 months, whereas this association
was lacking in patients with minor depression (Table 10).
Table 10. Association of depression at three months post-stroke with functional
outcome as measured by the Rankin Scale at 15 months (%).
Definition of depression RS I–II RS III–IV All P
Psychiatric examination 163 93 256
DSM III R major depression 34 (20.9) 32 (34.4) 66 (25.8) <0.05
Minor depression 12 (13.0) 20 (12.2) 32 (12.5) n.s.
Evaluated by BDI 154 236 390
BDI≥10 depression 78 (33.1) 93 (60.4) 171 (43.9) <0.0001
Likewise, major depression at three months was associated with a worse out-
come or dependence in ADL functions as defined by a BI <17 (35.5% vs. 22.7%,
χ2 = 4.03, d.f.=1).
Logistic regression analyses showed that depression (BDI≥10) at three months
post-stroke correlated with poor functional outcome at 15 months (OR 2.50,
95% CI 1.60–3.76), whereas poor outcome at three months was not associated
with depression at 15 months.
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DISCUSSION
Methodological aspects
Anterior, and especially left anterior lesion location have been previously relat-
ed to depression in many reports (Robinson et al., 1983a, Åström et al., 1993,
Starkstein et al., 1988, Herrmann et al., 1995) but not in all (Gainotti et al., 1997,
MacHale et al., 1998, Sharpe et al., 1990). The most influential meta-analysis in
this field, by Carson et al (2000a), failed to find any proven association between
lesion location and post-stroke depression. This topic is one of the greatest
controversies in neuropsychiatry, seriously affected by confusion on methodo-
logical issues (Singh et al., 1998). Among the most critical issues are patient
identification (i.e., adequate diagnostic procedure for depression), and accu-
rate stroke lesion identification and characterization.
Another important factor in PSD studies is the source of subjects: usually se-
lected from either hospital- or community-based populations. A recent system-
atic meta-analysis revealed among studies of hospital inpatients an association
mostly between left-hemisphere stroke and depression, whereas in communi-
ty-based studies, depression occurred more after right-hemisphere infarcts
(Bhogal et al., 2004). It is possible that such differences reflect different practic-
es in organizing stroke management in different areas. For instance, in Sweden,
90% of all stroke patients are admitted to a hospital (Åström et al., 1993), whereas
some studies have been conducted in regions where fewer than 50% of the
stroke patients are admitted to a hospital (House et al., 1990). In Finland, and
especially in the catchment area of the present study, virtually every patient is
treated in hospital during the acute phase of a stroke. Our original patient sam-
ple is thus representative of stroke patients in general. Among studies of lesion
location and PSD, our study is also by far the largest and the first one to employ
MRI technology. The largest CT-based studies in this field have recruited around
150 patients (Kim and Choi-Kwon, 2000, Gainotti et al., 1999).
It has been proposed that major and minor depression after stroke are two
different disorders (Gainotti et al., 1997, Morris et al., 1994), (Paradiso and
Robinson, 1999). This subject is still controversial, however, as diagnosing major
vs. minor depression in post-stroke elderly patients by present diagnostic crite-
ria is difficult (Gainotti et al., 1997). These patients often have dementia, dys-
phasia, or cognitive symptoms that may mimic or obscure depressive symp-
toms. Another important behavioral syndrome post-stroke, with key features of
emotional blunting and loss of interest and motivation, is apathy, which is present
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in 20% of stroke patients; and about half of these patients are also depressed
(Starkstein et al., 1993). Another frequent feature of PSD is post-stroke fatigue.
“Primary” fatigue – that presenting without depression – is also common, often
associated with brain-stem and thalamic lesions (Staub and Bogousslavsky,
2001).
Due to these uncertainties, we did not choose to distinguish between different
depressive syndromes, but included patients with any depressive disorder. It is,
however, obvious that the concept of post-stroke depression needs to be re-
framed. More accurate diagnostic criteria for PSD would be useful for both clin-
ical and scientific work, and these criteria would probably in many ways be
identical or analogous to the suggested criteria for vascular depression.
At 15 months’ follow-up, we chose to use BDI for identifying patients with de-
pression. While not as accurate as a clinical psychiatric examination, it has
been widely used in stroke patients (House et al., 1989a). The cut-off point of
≥10 points for depression has been useful for patients with somatic illnesses
(Beck and Beamesderfer, 1974, Beck, 1988).
As executive dysfunction is a poorly defined concept, many differing methods
have served to measure it (Royall et al., 2002). Even the leading authors in this
field have often used narrow and one-sided instruments to evaluate this com-
plex disorder (Alexopoulos et al., 2002), which reflects the lack of generally
accepted and validated methodology. We wanted to cover the most important
aspects of executive functions by using many widely used neuropsychological
tests and combining their results in a sum variable. We also excluded patients
with dementia, as correlations between radiological findings and many aspects
of poor cognitive function in demented patients would be difficult.
Most previous CT-based studies have used simple descriptions of lesion loca-
tions such as distance from the frontal pole of the brain, and only recently have
more detailed atlas-based lesion analyses been applied (Singh et al., 1998).
Magnetic resonance imaging is superior to CT in detecting the site, type, and
extent of infarcts, especially in the deep gray matter structures.. Sensitivity of
the MRI in detecting small deep lesions is one probable factor explaining some
of the differences between previous findings and ours.
Our studies have some important limitations. First, because the older, more
handicapped, and more cognitively impaired patients were more often exclud-
ed from demanding neuropsychological, neuroradiological, and psychiatric ex-
aminations, our results should be generalized in elderly stroke populations with
caution. Second, although MRI is more accurate than CT in localizing brain
lesions, the visually analyzed scans still give only an estimate of lesion sizes
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and locations. Large brain infarcts affecting, for example, the basal ganglia over-
lap many anatomical sites, complicating the analysis. On the other hand, small
and possibly critical sites like many of the small limbic structures may remain
undetected as correlates of PSD, either because stroke rarely affects them, or
because they were not detailed in the radiological ratings.
MRI correlates of post-stroke depression
We first evaluated depression in the naturalistic cohort including all patients, as
most of the patients treated for symptoms of acute brain infarct have, in MRI,
more than one infarct visible. Indeed, our patients had on an average 3.2 brain
infarcts. Any depression (minor or major) was present in 109 (40%) of the pa-
tients three months post-stroke. This is in accordance with most other findings
(Table 3).
These results suggest that stroke lesion location is one of the significant factors
affecting emotional and cognitive outcome in patients with stroke. Depression
was related to ischemic lesions affecting the frontal-subcortical circuit, namely
the caudate, the pallidum, the genu of the internal capsule, and the anterior
capsule, especially in the left hemisphere. In multivariate analysis, the inde-
pendent correlates of PSD were number of infarcts in the genu of the internal
capsule on the left side (OR 3.2) and the number of lesions in the pallidum of
either side (OR 1.6). The role of the pallidum was confirmed in the analyses in
which we included only patients with one single infarct on MRI. In this model,
the number of patients was reduced to only 70, but even in this model a brain
infarct affecting the pallidum was a strong correlate of post-stroke depression in
multivariate analysis (OR 7.2).
Evidence for the importance of the pallidum in mood regulation is emerging
from neuropathological studies (Baumann et al., 1999), as well as from experi-
ence with psychiatric complications of neurosurgical treatment of Parkinson’s
disease (Burn and Troster, 2004). Lesions affecting the pallidum have been
related to reduced glutamatergic input to the dorsolateral prefrontal cortex and
to depression (Lauterbach, 1999). In both of the models, univariate analysis
also revealed, however, many other locations that, when damaged by brain
infarcts, were associated with depression (Tables 5 and 6). Many of these struc-
tures, e.g., the pallidum, internal capsule, and caudate, belong to the frontal-
subcortical circuitry that has recently been associated with the frontal control of
motor, cognitive, and emotional functions (Cummings, 1995). Laterality seems
also to be important, with a left side lesion predominance in depressed patients.
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Our study showed also that the volumes of the brain infarcts affecting the ana-
tomical regions most often damaged by the infarcts in depressed patients were
larger. Thus, the infarcts of the depressed patients probably were more of the
large, cortical-subcortical type, rather than small lacunes. However, since large
infarcts cause prominent symptoms like hemiparesis that lead patients to seek
treatment promptly, the role of lacunes cannot reliably be assessed in the present
material.
Other critical lesion sites in these two models were the posterior corona radiata
and occipital lobes. In the first model, where every brain infarct was calculated,
the right occipital location was less common in patients with depression. On the
other hand, in the more restrictive model with only those patients having one
and only one brain infarct, the left occipital lesions were associated with a
higher risk for depression. This same phenomenon was reflected in the increased
frequency of brain infarcts affecting the left posterior corona radiata (white mat-
ter connections from the brain stem and basal ganglia to the posterior cortex) in
patients with depression. The role of the occipital lobe in depression is yet un-
clear, although occipital metabolic (Sanacora et al., 2004) and structural white
matter changes (Kumar et al., 2004) have been reported in patients with en-
dogenous and late-life depression.
The distinct frontal-subcortical circuits, i.e., orbitofrontal, dorsolateral, and an-
terior cingulate circuits, run closely adjacent to each other in the white matter
connections of the internal capsule and are likely to be damaged together in
case of an infarct in that area. Tatemichi et al. (1992) showed that an infarct
affecting the genu of the internal capsule was related to dementia and ”frontal
lobe symptoms.” It was surprising that the extent of white matter changes in
different areas did not correlate with PSD, as frontal white matter lesions are
one of the core features of vascular depression in general (Krishnan et al.,
1997, Greenwald et al., 1998, Thomas et al., 2003b). White matter changes in
PSD have not been previously studied. It is possible that the effect of white
matter changes on depression is less clear in post-stroke patients than in the
general elderly population, in which this association has been reported.
MRI correlates of executive dysfunction
The association between brain infarct localization and executive dysfunction
has not been studied systematically before. The prevalence of executive dys-
function in our sample was 34.1, but the excluded patients were significantly
older and cognitively more impaired. In such patients, executive dysfunction is
common, so our prevalence of executive dysfunction is probably lower than in
elderly stroke patients in general.
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In case reports, lesion location in the caudate (Caplan et al., 1990), in the thala-
mus (Ghika-Schmid and Bogousslavsky, 2000), or in the multiple subcortical la-
cunae (Wolfe et al., 1990) has been associated with executive dysfunction. In
our study, patients with executive dysfunction had more brain infarcts, particularly
in the left hemisphere. Further, these infarcts more often affected basal ganglia
(putamen and pallidum), the white matter connections therefrom (anterior corona
radiata and centrum semiovale), and frontal-subcortical circuits as a whole, with
left-side predominance. These findings fit well with the hypothesis that dorsola-
teral frontosubcortical circuits regulate executive functions (Cummings, 1995).
White matter lesions have been associated with executive dysfunction (Desmond,
2002), possibly due to a disconnection between deep brain structures and corti-
cal areas. Our results confirm the role of white matter lesions.
Periventricular, subcortical, and deep (centrum semiovale) white matter chang-
es were clearly more extensive in patients with executive dysfunction than in
those without. Analogous findings of the effects of the severity of white matter
changes on executive function in patients with lacunar infarcts have also re-
cently appeared (Wen et al., 2004). On the other hand, white matter changes
may affect cognitive function in stroke patients even at early stages, when the
subtle white matter changes are detected only by the more sophisticated diffu-
sion tensor MRI technology (O'Sullivan et al., 2004).
We also found that certain posterior structures, i.e., the pons and posterior cen-
trum semiovale, were associated with executive dysfunction. In fact, in multiple
logistic regression analysis, the only anatomical brain infarct correlates of ex-
ecutive dysfunction were location in the left pons (OR, 3.9) and posterior cen-
trum semiovale (OR 4.1). This may, at least in part, be explained by the fact that
patients with pontine brain infarcts had a higher number of brain infarcts overall
than did other patients; and that they also had more severe white matter chang-
es than did those  with other lesion locations. Thus, patients with pontine brain
infarcts in our series had a more severe cerebrovascular disease, which was
associated with more severe cognitive changes.
However, thalamocerebellar connections, which are further connected to fron-
tal-subcortical circuitry, also pass through the pons. The cognitive and behavio-
ral consequences of subtentorial stroke have received little attention (Malm et
al., 1998). Our results support in part the accumulating evidence from both
animal models (Keating and Winn, 2002, Winn, 1998) and patient series
(Schmahmann and Sherman, 1998), of the role of thalamocerebellar circuits as
a continuum with the frontal-subcortical circuits serving executive functions.
Executive dysfunction was also associated with central and medial temporal
atrophy. The strong association of medial temporal atrophy with executive dys-
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function may reflect emerging Alzheimer-type pathology in these non-dement-
ed patients with a heavy vascular risk-factor load. White matter changes, brain
atrophy, and brain infarcts probably interact in a deleterious manner, and may
lead to dementia (Pohjasvaara et al., 2000). Our findings suggest that in non-
demented stroke patients the number and localization of the brain infarcts to-
gether with white matter changes and brain atrophy contribute to executive
dysfunction.
Depression-executive dysfunction syndrome after stroke
In clinical practice, one often sees elderly patients recovering from stroke who
also suffer from depression and whose rehabilitation seems to take longer than
expected even when their depression is adequately treated. These patients
often suffer from post-stroke dementia, a common complication of stroke, af-
fecting up to one-third of elderly stroke patients (Pohjasvaara et al., 1998a).
However, those patients who are not demented may suffer from a disorder that
Alexopoulos has called depression-executive dysfunction syndrome (Alexopou-
los et al., 2002). Although this hypothesis has attracted much interest in leading
psychiatric journals, most of the papers have been produced by a single study
group at Cornell University. The concept originally served to define any patient
with late-onset depression – with or without stroke – in whom the depression
may be caused by any age-related or vascular damage to the fronto-subcorti-
cal circuitry.
Many of our  patients in our original cohort had to be excluded, and the remain-
ing 158 patients represented the younger and the less handicapped subgroup
of elderly stroke patients. Of these individuals, 21 (13.3%) had both depression
and executive dysfunction. In clinical practice, where patients cannot be ex-
cluded, the proportion of DES among stroke victims is probably clearly higher.
We found no differences in severity of depressive symptoms (as measured by
the MADRS) between these two patient groups. However, clinicians have rec-
ognized depression in patients with DES more often than in patients without
executive dysfunction: 71% of our patients with DES received antidepressive
medication compared with 41% of our patients with depression without execu-
tive dysfunction.
Patients with DES had more brain infarcts affecting substructures of the frontal-
subcortical circuits, especially the pallidum, anterior internal capsule, and cau-
date, than did our patients with DES. Within the depressed patient population,
those with DES had more brain infarcts affecting mostly left-sided frontal-sub-
cortical structures than did  those depressed patients without executive dys-
function. Further, those with executive dysfunction but without depression also
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had more brain infarcts affecting the length of the frontal-subcortical circuits.
These results support the still somewhat hypothetical idea of anatomical circuit
substrates in differing neuropsychiatric disorders. Executive dysfunction has
been associated with the dorsolateral prefrontal system, and depression with
the dorsolateral and orbitofrontal systems (Tekin and Cummings, 2002). Thus,
stroke patients presenting with both executive dysfunction and mood distur-
bances should more likely have structural lesions affecting frontal-subcortical
circuitry than would patients with depression but without executive dysfunction
– as indeed was the case in our patients.
Our findings also suggest that the novel hypothesis of DES may be valid in stroke
patients. In this subgroup of vascular depression, however, the frontal-subcorti-
cal disruption is caused by brain infarcts rather than by white-matter changes.
That we found no correlation between extent of  white-matter changes and DES
is not surprising, since each of our patients had a severe cerebrovascular dis-
ease by definition, and the effect of brain infarcts on cognitive and mood disor-
ders per se is probably much more robust than that of white-matter changes.
Post-stroke depression and functional outcome after stroke
The association between post-stroke depressive symptoms and consequent
functional outcome has been reported in longitudinal studies (Singh et al., 2000,
Kotila et al., 1999, Herrmann et al., 1998). In another of our studies from the
Stroke Aging Memory cohort, we have also reported that higher BDI score at
three months is associated with less independent functioning at 15 months af-
ter stroke (Pohjasvaara et al., 2002b). Each point of worsening in BDI had an
independent effect on dependent living at 15 months after stroke. The present
study found that those patients with depression at three months after stroke
(minor or major), or patients with major, but not minor depression, had worse
functional outcome, being both more handicapped (RS>II) and more depend-
ent in activities of daily living (BI>17 points) than were those without depression
after 15 months’ follow-up.
Recognition and adequate treatment of depression should therefore be an im-
portant part of stroke treatment. Our patients had received a standard medical
and neurological evaluation and treatment before their enrollment at three months.
Of our patients with depression, 23% received antidepressive medication at three
months. In community-based studies, the reported use of antidepressants in pa-
tients with PSD is less that 20% (Kotila et al., 1998). A more pragmatic and active
approach in management of PSD is clearly needed, as a better outcome in reha-
bilitation (Narushima and Robinson, 2003) and even in survival (Jorge et al.,
2003) has been associated with early antidepressive medication.
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Frontal-subcortical ischemic lesions in vascular depression (Alexopoulos et al.,
1997b), dysfunction of  frontal-subcortical circuitry in major depression (Dunkin
et al., 2000), and executive dysfunction in PSD (Downhill and Robinson, 1994)
have been connected with chronicity of depression. One of the fundamental
questions to be answered in future studies is the possible association of PSD
with incident vascular dementia. The anatomical, subcortical correlates of PSD
reported in this study are similar to those of post-stroke dementia, reported by
Pohjasvaara et al (2000) from this same patient cohort, and reports of others
(Tatemichi et al., 1992, Censori et al., 1996).
Vascular dementia may be caused by multiple strokes but also by a single stra-
tegic stroke, multiple lacunae, and hypoperfusive lesions such as border zone
infarcts and ischemic periventricular leukoencephalopathy (Binswanger’s dis-
ease) (Erkinjuntti et al., 2000b). This lesion profile is very similar or identical to
that of patients with vascular depression, PSD, or DES. Thus, vascular depres-
sion and PSD should probably be considered as warning signs for emerging
vascular dementia (Steffens et al., 2003),  especially when cognitive disorder is
already present, as in patients with DES. Recognition of PSD and prompt man-
agement of vascular risk factors may diminish that risk. Further, patients with
PSD or DES may also become a target group for trials with novel compounds
like galantamine (Erkinjuntti et al., 2002) or D3 -agonists (Alexopoulos, 2001) or
more specific antidepressants both to treat and to prevent cognitive decline
after stroke.
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CONCLUSIONS
1) Lesion location was an important determinant of PSD. Brain infarcts affect-
ing frontal-subcortical circuitry, especially in the left hemisphere, increased
the risk for PSD. The importance of subcortical lesions affecting basal gan-
glia and the frontal-subcortical white matter connections for PSD is high-
lighted.
2) Like depression, executive dysfunction was also associated with damage
to the frontal-subcortical circuit structures. However, posterior lesions like
pontine brain infarcts were also correlated with executive dysfunction. Fur-
ther, white matter lesions and brain atrophy were important correlates of
executive dysfunction post-stroke, but not PSD. Our results support the
novel model of the frontal-subcortical circuit system as a regulator and
modulator of cognitive functions and emotions.
3) Patients with DES had more brain infarcts affecting their frontal-subcortical
structures than did those patients, who had either depression or executive
dysfunction alone, or had neither. DES affected at least 13% of our elderly
patients post-stroke. These patients were more disabled in activities of daily
living and had more cognitive symptoms as measured by the MMSE. Fur-
ther studies are needed to further characterize the phenomenology, preva-
lence, prognosis, and possibly more specific management options of DES.
4) Depression was an independent predictor of poor functional long-term out-
come in stroke patients. We emphasize the importance of early recognition
and management of depression post-stroke.
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